{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383670319965545472.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"R Zahler"}],"foaf:familyName":[{"@value":"Zahler"}],"foaf:givenName":[{"@value":"R"}]}],"career":[{"institution":{"notation":[{"@value":"Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492-7660, USA."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363670319965545600","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1128/aac.41.7.1444"},{"@type":"URI","@value":"https://journals.asm.org/doi/pdf/10.1128/AAC.41.7.1444"}],"notation":[{"@value":"Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1128/aac.41.7.1444_HA1jbjWqkBzFSj0Vpi2b4ghJ5c3"}]}